Whitehawk Therapeutics (WHWK) Shares Outstanding (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 12 years of Shares Outstanding (Entity) data on file, last reported at $8.9 million in Q4 2021.

• On a quarterly basis, Shares Outstanding (Entity) rose 183.26% year-over-year to $8.9 million in Q4 2021; TTM through Dec 2021 was $8.9 million, a 183.26% increase from a year earlier, with the FY2021 full-year figure at $8.9 million, up 183.26% from the prior year.
• Shares Outstanding (Entity) for Q4 2021 stood at $8.9 million, down from $9.5 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for WHWK reached as high as $9.5 million in Q3 2021 and fell as low as $373695.0 in Q1 2017.
• Historically, Shares Outstanding (Entity) has averaged $3.1 million across 5 years, with a median of $2.7 million in 2018.
• Across the five-year window, Shares Outstanding (Entity) surged 441.4% in 2017 and changed 0.0% in 2019, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $1.4 million in 2017, then jumped by 87.27% to $2.7 million in 2018, then changed by 0.0% to $2.7 million in 2019, then gained by 16.42% to $3.2 million in 2020, then surged by 183.26% to $8.9 million in 2021.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $8.9 million in Q4 2021, $9.5 million in Q3 2021, and $3.2 million in Q2 2021.